Match each end-of-life clinical scenario to the most appropriate next step in symptom management.
- A 71-year-old with end-stage idiopathic pulmonary fibrosis who is restless, using accessory muscles, and complaining of severe air hunger despite continuous oxygen therapy.Initiate systemic therapy with a low-dose opioid
- A 68-year-old with metastatic glioblastoma who is unresponsive in the final days of life, exhibiting coarse, noisy breathing sounds caused by the pooling of oropharyngeal secretions.Administer an anticholinergic medication
- A 55-year-old with advanced cervical cancer on high-dose intravenous morphine who develops generalized hyperalgesia, confusion, and frequent myoclonic jerks.Perform an opioid rotation
- A 64-year-old with an apical lung tumor who experiences paroxysms of severe, electric-shock-like pain radiating down the medial aspect of the left forearm.Initiate an adjuvant neuromodulating agent
Answer
Refractory dyspnea is managed with systemic low-dose opioids. Terminal secretions are treated with anticholinergic medications. Opioid-induced neurotoxicity requires opioid rotation. Neuropathic pain requires an adjuvant neuromodulating agent.
Optimal end-of-life care relies on accurately matching specific symptoms with their most effective treatments. Low-dose opioids effectively reduce the central perception of dyspnea. Anticholinergic medications dry up pooled oropharyngeal secretions that cause the 'death rattle'. Opioid rotation clears accumulated neurotoxic metabolites while maintaining analgesia. Finally, neuropathic pain requires targeted adjuvant therapy like gabapentinoids.
Step-by-Step Solution
Key Concept
Palliative pharmacologic symptom management